Pacific Northwest Prostate Cancer SPORE Gets $11.3M in NCI Renewal Funds | GenomeWeb

NEW YORK (GenomeWeb News) – The Fred Hutchinson Cancer Research Center has won an $11.3 million competitive renewal grant from the National Cancer Institute to continue funding for a prostate cancer research consortium that pursues a range of projects focused on genetic and molecular medicine.

The grant renews support of the Pacific Northwest Prostate Cancer SPORE (Specialized Programs of Research Excellence) program, which launched in 2002, Fred Hutch said today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: characterization of functional genomic features in breast cancer cell lines, epigenetic pattern linked to obesity, and more.

President Obama's proposed budget for fiscal year 2017 includes an increase for NIH, but seeks some of it as mandatory funding.

Sure Genomics begins to offer direct-to-consumer genome sequencing for $2,500.

Intelligence officials in the US have added gene editing to a list of weapons of mass destruction.